← FDA Drug Approvals (Drugs@FDA)

BROMOCRIPTINE MESYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2005-04-04

Drug application

FDA Application #

ANDA077226

Application type

Abbreviated New Drug Application (Generic)

Brand name

BROMOCRIPTINE MESYLATE

Generic name

BROMOCRIPTINE MESYLATE

Active ingredients

BROMOCRIPTINE MESYLATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

MYLAN

Manufacturer

Mylan Pharmaceuticals Inc.

First approval

2005-04-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown